HISTAMINE RECEPTOR AGONISTS FOR CANCER THERAPY IN CANCER PATIENTS UNRESPONSIVE TO CANCER… Application WO-2023009261-A1 World Intellectual Property Organisation (WIPO) 02 Feb 2023